Suppr超能文献

登革热和 COVID-19 合并感染的后果是否更严重?对现有证据的系统评价。

Does dengue and COVID-19 co-infection have worse outcomes? A systematic review of current evidence.

机构信息

Faculty of Medicine, Minia University, Minia, Egypt.

Faculty of Pharmacy, Minia University, Minia, Egypt.

出版信息

Rev Med Virol. 2022 Sep;32(5):e2339. doi: 10.1002/rmv.2339. Epub 2022 Feb 25.

Abstract

In dengue-endemic regions, the co-infection with SARS-CoV-2 and dengue is a significant health concern. Therefore, we performed a literature search for relevant papers in seven databases on 26 Spetember 2021. Out of 24 articles, the mortality rate and intensive care unit (ICU) admission were 19.1% and 7.8%, respectively. The mean hospital stay was 11.4 days. In addition, we identified two pregnancies with dengue and COVID-19 co-infection; one ended with premature rupture of membrane and intrauterine growth restriction fetus, while the other one ended with maternal mortality and intrauterine fetal death. COVID-19 and dengue co-infection had worse outcomes regarding mortality rates, ICU admission, and prolonged hospital stay. Thus, wise-decision management approaches should be adequately offered to these patients to enhance their outcomes. Establishing an early diagnosis might be the answer to reducing the estimated significant burden of these conditions.

摘要

在登革热流行地区,SARS-CoV-2 和登革热的合并感染是一个重大的健康问题。因此,我们在 2021 年 9 月 26 日在七个数据库中进行了相关文献的检索。在 24 篇文章中,死亡率和重症监护病房(ICU)入院率分别为 19.1%和 7.8%。平均住院时间为 11.4 天。此外,我们还发现了两例登革热和 COVID-19 合并感染的妊娠病例;一例以胎膜早破和宫内生长受限胎儿结束,另一例以产妇死亡和宫内胎儿死亡结束。COVID-19 和登革热合并感染的死亡率、ICU 入院率和住院时间延长的后果更差。因此,应该为这些患者提供明智的决策管理方法,以改善他们的预后。早期诊断可能是减轻这些疾病估计的巨大负担的答案。

相似文献

2
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.
4
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.SARS-CoV-2 中和单克隆抗体预防 COVID-19。
Cochrane Database Syst Rev. 2022 Jun 17;6(6):CD014945. doi: 10.1002/14651858.CD014945.pub2.
5
Ivermectin for preventing and treating COVID-19.伊维菌素预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2022 Jun 21;6(6):CD015017. doi: 10.1002/14651858.CD015017.pub3.
8
Treatment of COVID-19 in pregnant women: A systematic review and meta-analysis.妊娠期 COVID-19 的治疗:系统评价和荟萃分析。
Eur J Obstet Gynecol Reprod Biol. 2021 Dec;267:120-128. doi: 10.1016/j.ejogrb.2021.10.007. Epub 2021 Oct 20.

引用本文的文献

4
Severe dengue in the intensive care unit.重症监护病房中的严重登革热。
J Intensive Med. 2023 Sep 28;4(1):16-33. doi: 10.1016/j.jointm.2023.07.007. eCollection 2024 Jan.
6
COVID-19 and monkeypox co-infection: A rapid systematic review.COVID-19 与猴痘合并感染:快速系统评价。
Front Immunol. 2022 Dec 14;13:1094346. doi: 10.3389/fimmu.2022.1094346. eCollection 2022.
7
COVID-19 and dengue coinfection in Latin America: A systematic review.拉丁美洲的新冠病毒与登革热合并感染:一项系统综述。
New Microbes New Infect. 2022 Nov-Dec;49:101041. doi: 10.1016/j.nmni.2022.101041. Epub 2022 Oct 28.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验